IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine
Go back to IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine| Waters Corporation (NYSE: WAT) | Delayed: 380.37 +9.55 (2.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $370.82 | 52 Week High | $162.53 | |||
| Open | $378.94 | 52 Week Low | $112.00 | |||
| Day High | $389.99 | P/E | 73.15 | |||
| Day Low | $375.05 | EPS | $5.20 | |||
| Volume | 704,721 | |||||

